Literature DB >> 30131606

Estrogens and prostate cancer.

Ryan W Dobbs1, Neha R Malhotra1, David T Greenwald1, Alice Y Wang2, Gail S Prins1, Michael R Abern3.   

Abstract

BACKGROUND: Hormonal influences such as androgens and estrogens are known contributors in the development and progression of prostate cancer (CaP). While much of the research to the hormonal nature of CaP has focused on androgens, estrogens also have critical roles in CaP development, physiology as well as a potential therapeutic intervention.
METHODS: In this review, we provide a critical literature review of the current basic science and clinical evidence for the interaction between estrogens and CaP.
RESULTS: Estrogenic influences in CaP include synthetic, endogenous, fungi and plant-derived compounds, and represent a family of sex hormones, which cross hydrophobic cell membranes and bind to membrane-associated receptors and estrogen receptors that localize to the nucleus triggering changes in gene expression in various organ systems.
CONCLUSIONS: Estrogens represent a under-recognized contributor in CaP development and progression. Further research in this topic may provide opportunities for identification of environmental influencers as well as providing novel therapeutic targets in the treatment of CaP.

Entities:  

Year:  2018        PMID: 30131606     DOI: 10.1038/s41391-018-0081-6

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  20 in total

1.  Differential Actions of Estrogen Receptor α and β via Nongenomic Signaling in Human Prostate Stem and Progenitor Cells.

Authors:  Shyama Majumdar; Jaqueline C Rinaldi; Neha R Malhotra; Lishi Xie; Dan-Ping Hu; Timothy D Gauntner; Harinder S Grewal; Wen-Yang Hu; Sung Hoon Kim; John A Katzenellenbogen; Susan Kasper; Gail S Prins
Journal:  Endocrinology       Date:  2019-11-01       Impact factor: 4.736

Review 2.  The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer.

Authors:  Liuxun Li; Jiangli Xu
Journal:  Clin Transl Oncol       Date:  2022-10-06       Impact factor: 3.340

Review 3.  Prostate cancer in transgender women: considerations for screening, diagnosis and management.

Authors:  Fionnuala Crowley; Meredith Mihalopoulos; Simita Gaglani; Ashutosh K Tewari; Che-Kai Tsao; Miroslav Djordjevic; Natasha Kyprianou; Rajveer S Purohit; Dara J Lundon
Journal:  Br J Cancer       Date:  2022-10-19       Impact factor: 9.075

Review 4.  Embryologic and hormonal contributors to prostate cancer in transgender women.

Authors:  Simita Gaglani; Rajveer S Purohit; Ashutosh K Tewari; Natasha Kyprianou; Dara J Lundon
Journal:  Am J Clin Exp Urol       Date:  2022-04-15

5.  Estrogens and development of the rete testis, efferent ductules, epididymis and vas deferens.

Authors:  Rex A Hess; Richard M Sharpe; Barry T Hinton
Journal:  Differentiation       Date:  2020-12-13       Impact factor: 3.880

Review 6.  An approach to classifying occupational exposures to endocrine disrupting chemicals by sex hormone function using an expert judgment process.

Authors:  R Prichystalova; E Caron-Beaudoin; L Richardson; E Dirkx; A Amadou; T Zavodna; R Cihak; V Cogliano; J Hynes; L Pelland-St-Pierre; M A Verner; M van Tongeren; V Ho
Journal:  J Expo Sci Environ Epidemiol       Date:  2020-07-23       Impact factor: 5.563

7.  Osteoblasts Generate Testosterone From DHEA and Activate Androgen Signaling in Prostate Cancer Cells.

Authors:  Henry H Moon; Katrina L Clines; Patrick J O'Day; Basel M Al-Barghouthi; Emily A Farber; Charles R Farber; Richard J Auchus; Gregory A Clines
Journal:  J Bone Miner Res       Date:  2021-05-18       Impact factor: 6.390

Review 8.  The Relationship between Estrogen-Related Signaling and Human Papillomavirus Positive Cancers.

Authors:  Claire D James; Iain M Morgan; Molly L Bristol
Journal:  Pathogens       Date:  2020-05-22

9.  Severe Vasomotor Symptoms Post-Oophorectomy Despite Testosterone Therapy in a Transgender Man: A Unique Case Study.

Authors:  Isabel Casimiro; Ronald N Cohen
Journal:  J Endocr Soc       Date:  2019-02-13

10.  Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma.

Authors:  Paola Ostano; Maurizia Mello-Grand; Debora Sesia; Ilaria Gregnanin; Caterina Peraldo-Neia; Francesca Guana; Elena Jachetti; Antonella Farsetti; Giovanna Chiorino
Journal:  Int J Mol Sci       Date:  2020-02-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.